Glatiramer acetate triggers PI3Kδ/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes

Lignende værker

• Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1β in human monocytes and multiple sclerosis
  af: Burger, Danielle, et al.
  Udgivet: (2009)
• IFNβ and glatiramer acetate trigger different signaling pathways to regulate the IL-1 system in multiple sclerosis
  af: Carpintero, Rakel, et al.
  Udgivet: (2011)
• HDL Interfere with the Binding of T Cell Microparticles to Human Monocytes to Inhibit Pro-Inflammatory Cytokine Production
  af: Carpintero, Rakel, et al.
  Udgivet: (2010)
• Glatiramer acetate treatment negatively regulates type I interferon signaling
  af: Molnarfi, Nicolas, et al.
  Udgivet: (2015)
• Glatiramer Acetate in the Treatment of Multiple Sclerosis: Emerging Concepts Regarding its Mechanism of Action
  af: Lalive, Patrice H., et al.
  Udgivet: (2011)